1-4 of 4
Samuel K. Kulp
Close
Sort by
Journal Articles

Increased Expression Of IL-15 Promotes Cutaneous T-Cell Lymphomagenesis Via The Upregulation Of Histone Deacetylases: Evidence For Successful Preclinical Targeting

Anjali Mishra, Ph.D., Krista M.D. La Perle, DVM, PhD, Dipl. ACVP, Laura Sullivan, BS, Gregory H Sams, Douglas P Curphey, Kathleen McConnell, BS, Jun Qi, PhD, Henry K Wong, MD, PhD, Samuel K Kulp, PhD, Soledad Fernandez, PhD, James E Bradner, MD, Guido Marcucci, MD, Ching-Shih Chen, PhD, Pierluigi Porcu, MD, Michael A. Caligiuri, MD
Journal: Blood
Blood (2013) 122 (21): 1826.
https://doi.org/10.1182/blood.V122.21.1826.1826
Published: 2013
Journal Articles

AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit

Tzu-Yin Lin, Joelle Fenger, Sridhar Murahari, Misty D. Bear, Samuel K. Kulp, Dasheng Wang, Ching-Shih Chen, William C. Kisseberth, Cheryl A. London
Journal: Blood
Blood (2010) 115 (21): 4217–4225.
https://doi.org/10.1182/blood-2009-07-231985
Published: 2010
Journal Articles

OSU-DY7, a Novel D -Tyrosinol Derivative, Mediates Cytotoxicity in Chronic Lymphocytic Leukemia and Lymphoblastic Lymphoma through p38 Mitogen-Activated Protein Kinase Pathway.

Li-Yuan Bai, MD, Yihui Ma, Samuel K Kulp, Shu-Huei Wang, PhD, Chang-Fang Chiu, MD, DMS, Frank Frissora, Xiaokui Mo, David Jarjoura, John C. Byrd, Ching-Shih Chen, Natarajan Muthusamy, DVM., PhD
Journal: Blood
Blood (2009) 114 (22): 3778.
https://doi.org/10.1182/blood.V114.22.3778.3778
Published: 2009
Journal Articles

The Novel Histone Deacetylase Inhibitor OSU-HDAC42 Has Class I and II Histone Deacetylase (HDAC) Inhibitory Activity and Represents a Novel Therapy for Chronic Lymphocytic Leukemia.

Derek A. West, BS, David M. Lucas, PhD, Melanie E. Davis, PhD, Michael D. De Lay, BA, Amy J. Johnson, PhD, Sara E. Guster, MS/MBA, Michael A. Freitas, PhD, Mark R. Parthun, PhD, Dasheng Wang, PhD, Samuel K. Kulp, PhD/DVM, Michael R. Grever, MD, Ching-Shih Chen, PhD, John C. Byrd, MD
Journal: Blood
Blood (2006) 108 (11): 2807.
https://doi.org/10.1182/blood.V108.11.2807.2807
Published: 2006